THERAPEUTISCHE BEHANDLUNG

Patent europeic · EP2694056 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2694056
Numer da la dumonda
EP12715421
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
02-04-2012
Publitgà
12-02-2014
Concedì
16-10-2019
La protecziun finescha il pli tard
01-04-2032
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
A61K 31/337 (2006.01)
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 201161470668 P 01.04.2011
Dumonda PCT
PCT/GB2012/050736 02.04.2012
Publicaziun PCT
WO2012/131399 04.10.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  2. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  3. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  4. 16-10-2019

    Concedì

    Published in Swissreg on 16.10.2019

Partidas

Possessur

AstraZeneca AB

151 85 Södertälje, SE

Inventur

DAVIES, Barry, Robert

Macclesfield, Cheshire SK10 4TG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.